The University of Chicago Header Logo

Connection

Olwen Hahn to Evaluation Studies as Topic

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Evaluation Studies as Topic.
Olwen Hahn
Connection Strength
0.043
Evaluation Studies as Topic
  1. Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials. Eur J Cancer. 2019 08; 117:91-98.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.